Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of normal, metaplastic, and neoplastic esophageal extracellular matrix upon macrophage activation.
Saldin LT, Klimak M, Hill RC, Cramer MC, Huleihel L, Li X, Quidgley-Martin M, Cardenas D, Keane TJ, Londono R, Hussey G, Kelly L, Kosovec JE, Lloyd EJ, Omstead AN, Zhang L, Nieponice A, Jobe B, Hansen K, Zaidi AH, Badylak SF. Saldin LT, et al. Among authors: huleihel l. J Immunol Regen Med. 2021 Aug;13:100037. doi: 10.1016/j.regen.2020.100037. Epub 2020 Dec 28. J Immunol Regen Med. 2021. PMID: 34027260 Free PMC article.
Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype.
Saldin LT, Patel S, Zhang L, Huleihel L, Hussey GS, Nascari DG, Quijano LM, Li X, Raghu D, Bajwa AK, Smith NG, Chung CC, Omstead AN, Kosovec JE, Jobe BA, Turner NJ, Zaidi AH, Badylak SF. Saldin LT, et al. Among authors: huleihel l. Tissue Eng Part A. 2019 Mar;25(5-6):487-498. doi: 10.1089/ten.TEA.2018.0105. Tissue Eng Part A. 2019. PMID: 30259795 Free PMC article.
Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D, Zaidi AH, Martin SA, Omstead AN, Kosovec JE, Huleihel L, Saldin LT, DiCarlo C, Silverman JF, Hoppo T, Finley GG, Badylak SF, Kelly RJ, Jobe BA. Matsui D, et al. Among authors: huleihel l. Oncotarget. 2016 Dec 6;7(49):81281-81291. doi: 10.18632/oncotarget.12832. Oncotarget. 2016. PMID: 27793030 Free PMC article. Review.
Macrophage phenotype in response to ECM bioscaffolds.
Huleihel L, Dziki JL, Bartolacci JG, Rausch T, Scarritt ME, Cramer MC, Vorobyov T, LoPresti ST, Swineheart IT, White LJ, Brown BN, Badylak SF. Huleihel L, et al. Semin Immunol. 2017 Feb;29:2-13. doi: 10.1016/j.smim.2017.04.004. Epub 2017 Jul 21. Semin Immunol. 2017. PMID: 28736160 Free PMC article. Review.
Matrix-bound nanovesicles within ECM bioscaffolds.
Huleihel L, Hussey GS, Naranjo JD, Zhang L, Dziki JL, Turner NJ, Stolz DB, Badylak SF. Huleihel L, et al. Sci Adv. 2016 Jun 10;2(6):e1600502. doi: 10.1126/sciadv.1600502. eCollection 2016 Jun. Sci Adv. 2016. PMID: 27386584 Free PMC article.
Regenerative Medicine: lessons from Mother Nature.
Naranjo JD, Scarritt ME, Huleihel L, Ravindra A, Torres CM, Badylak SF. Naranjo JD, et al. Among authors: huleihel l. Regen Med. 2016 Dec;11(8):767-775. doi: 10.2217/rme-2016-0111. Epub 2016 Nov 25. Regen Med. 2016. PMID: 27885899 Free PMC article.
Extracellular Matrix Bioscaffolds as Immunomodulatory Biomaterials<sup/>
Dziki JL, Huleihel L, Scarritt ME, Badylak SF. Dziki JL, et al. Among authors: huleihel l. Tissue Eng Part A. 2017 Oct;23(19-20):1152-1159. doi: 10.1089/ten.TEA.2016.0538. Epub 2017 May 19. Tissue Eng Part A. 2017. PMID: 28457179 Free PMC article. Review.
26 results